May 7, 2024

Digitizing Biotech

Digitizing Biotech

In this episode of the Futurized podcast, host Trond Arne Undheim interviews Jason Paragas, CEO and founder of the startup DVLP about the prospect of blockchain-based drug development.
They discuss Paragas's work on digitizing biotech, making drug de...

In this episode of the Futurized podcast, host Trond Arne Undheim interviews Jason Paragas, CEO and founder of the startup DVLP about the prospect of blockchain-based drug development.

They discuss Paragas's work on digitizing biotech, making drug development more effective, and securing its use for the common good. His main point is that although drug development has been optimized for discovery, and is getting even better through AI, we have not optimized neither on clinical trials nor on manufacturing. We might not be able to speed up biology, but we can definitely speed up institutional quality control processes. This is especially relevant as drug development moves from mass production to mass customization. 

Futurized goes beneath the trends to track the underlying forces of disruption in tech, policy, business models, social dynamics and the environment.

I’m your host, Trond Arne Undheim (@trondau), futurist, scholar, author, investor, and serial entrepreneur. I am a Research scholar in Global Systemic Risk, Innovation, and Policy at Stanford University. Join me as I discuss the societal impact of deep tech such as AI, blockchain, IoT, nanotech, quantum, robotics, and synthetic biology, and tackle topics such as entrepreneurship, trends, or the future of work. On the show, I interview smart people with a soul: founders, authors, executives, and other thought leaders, or even the occasional celebrity.

Futurized is a bi-weekly show, preparing YOU to think about how to deal with the next decade's disruption, so you can succeed and thrive no matter what happens.

If you're new to the show, seek particular topics, or you are looking for a great way to tell your friends about the show, which we always appreciate, we've got the episode categories. Those are at Futurized.org/episodes. They are collections of your favorite episodes organized by topic, such as Entrepreneurship, Trends, Emerging Tech, or The Future of Work. That'll help new listeners get a taste of everything that we do here, starting with a topic they are familiar with, or want to go deeper in.

I am the author of Eco Tech: Investing in Regenerative Futures, Health Tech: Rebooting Society's Software, Hardware and Mindset, Future Tech: How to Capture Value from Disruptive industry Trends, Pandemic Aftermath: how Coronavirus changes Global Society, Disruption Games: How to Thrive on Serial Failure, and of Leadership From Below: How the Internet Generation Redefines the Workplace, and the co-author of Augmented Lean: A human-centric framework for managing frontline operations. For an overview, go to Trond's Books at Trondundheim.com/books

At this stage, Futurized is lucky enough to have several sponsors. To check them out, go to Futurized.org/sponsors

If you are interested in sponsoring the podcast, or to get an overview of other services provided by the host of this podcast, including how to book him for keynote speeches, please go to Futurized.org/store. We will consider all brands that have a demonstrably positive contribution to the future.

Before you do anything else, make sure you are subscribed to our newsletter on Futurized.org, where you can find hundreds of episodes of conversations that matter to the future. I hope you can also leave a positive review on iTunes or in your favorite podcast player--it really matters to the future of this podcast.  

Futurized—conversations that matter.

Jason ParagasProfile Photo

Jason Paragas

CEO and founder

Jason Paragas is the CEO and founder of the startup DVLP. Jason is a technology executive with a long track record of success in the life sciences industry. In addition to serving as a, he is the founder and president of a company that is using artificial intelligence, synthetic biology, and immunology to create the next breakthrough vaccine platform after mRNA. Prior to this, Jason served as VP of Valo Health, where he sourced technology, data, and partnerships for a leading AI drug discovery company. He also spent 20 years with the NIAID, DOD, DOE, and Lawrence Livermore National Laboratory, where he led projects that solved national and health security challenges with advanced technology and innovative public-private partnerships. Jason serves on several boards and is a sought-after advisor to new companies. He obtained a PhD in Microbiology from the Icahn School of Medicine at Mount Sinai.